Although the three phases involved in HER2 testing in breast cancer are important, the main challenges in the practical implementation of the recommendations of this consensus in Brazil are in the preanalytical phase that involves fixing, transporting to the laboratory, and sectioning of surgical specimens to avoid protein damage resulting from cold ischemia. Here, ERBB2 is linked to breast carcinoma.